A growing demand for portable and point-of-care sequencers (NGS) is expected to drive the market for next-generation ...

New strategies promise to streamline workflows, conserve consumables, increase productivity, and enhance reproducibility.

Representing the Director General of the National Institute for Cancer Research and Treatment (NICRAT), Dr. Arisegi Sarafedeen Adeniyi, said that the ...

Tumor molecular analysis using next-generation sequencing (NGS) is the standard of care for guiding lung cancer treatment.

Attendees included policy makers, renowned scientists, researchers, and medical specialists who deliberated on the advancement of Next-Generation Sequencing (NGS) technology to improve cancer ...

PredicineCARE™ played a critical role in identifying and enrolling patients with PIK3CA-mutated metastatic breast cancer in ...

The patients' lung cancer and disease stages were classified according ... and germline genomic DNA from peripheral blood ...

Adam Brufsky, MD, PhD, professor of medicine at the University of Pittsburgh School of Medicine; Megan Kruse, MD, breast medical oncologist at Cleveland Clinic; and Ruta Rao, MD, professor of medicine ...

The global market for cancer-focused genetic testing services is on a transformative growth trajectory, with projections estimating a market size of USD 8,472.70 million by 2024, and an expected ...

“We are thrilled to bring MI Cancer Seek to market to ensure patients have access to critical precision medicine tools.” The next-generation sequencing–based in vitro diagnostic device uses total ...

In cancer treatment, precision medicine uses specific information about a patient’s tumor to help make a diagnosis, plan ...